BERKELEY, CA--(Marketwire - October 04, 2011) - The UC Berkeley BioExec Institute, beginning tomorrow, Oct. 5 at the Haas School of Business, will bring together executive leaders in the life sciences from around the globe to address strategies that will help manage business issues of bringing innovative science -- within a highly regulated and competitive industry -- to the marketplace.
Delivered by industry specialists from the Deloitte Life Science Practice, UC Berkeley Center for Executive Education and Prescience International, the Institute offers attendees six-days of interactive programming from October through December 2011, including three evening networking receptions.
The BioExec Institute participants will have opportunities to debate the strategies and tactics of business leadership within biopharma. The goal of the program is to give the next generation of biopharma leaders a powerful platform of insights and networks to deliver bottom-line value in this dynamic industry.
"Quickly converting new discoveries to therapies continues to be a tremendous challenge faced by biopharmas globally," said Melinda Richter, president and CEO, Prescience International. "The BioExec Institute is one of the few places in the U.S. that brings together big company executives and innovators driving the industry to debate their business strategies," she said.
Now in its 8th year, the 2011 BioExec Institute, featuring themes surrounding creating, growing and managing value, showcases a broad spectrum of speakers representing all aspects of the industry -- from R&D to regulatory to marketing to business development.
"In addition to the stellar dialogue with a variety of business executives in different functions, the peer-to-peer networking is extremely valuable and is conducive to future collaborations," said Nina Malik, national director, Transplant & Infectious Disease, US Medical Affairs, Novartis Pharmaceutical Corporation.
Some of the speakers for the 2011 BioExec Institute include Mervyn J. Turner, former chief strategy officer, Merck & Co. Inc. & former sr. vice president, Emerging Markets, Merck Research Laboratories; Kristin Peck, executive vice president, Worldwide Business Development and Innovation, Pfizer; Bernard Munos, founder, InnoThink Center for Research in Biomedical Innovation; Bill Taranto, managing director, Merck Global Health Innovation Fund; Jamie Topper, general partner, Frazier Healthcare; Sanjay Kumar, vice president, Biology, at the Virtual Proof of Concept Discovery Performance Unit (VPoC DPU), GlaxoSmithKline, Chris Boerner, vice president, marketing, Seattle Genetics, Minnie Baylor Henry, worldwide vice president, Regulatory Affairs-Medical Devices & Diagnostics, Johnson & Johnson, and others.
The kick-off module for the 2011 BioExec Institute focuses on building the future scenarios of healthcare and examining the models of innovation that will be most effective in each of those scenarios. The first module sets the stage for the inter-relation between discovery and manufacturing, clinical trials, regulatory approvals and safety testing. Other modules on Nov. 2-3 and Dec. 7-8 will look at strategic product positioning, FDA regulatory environment, deal-making and executive leadership.
"Having a forum to foster innovative thinking, along with the opportunity to debate strategies for moving that thinking forward, and then arming the Institute participants with practical tools to implement that thinking, will help them, as the future leaders of our industry, speed treatments to those who need them most," said Keith Donnermeyer, Partner, Deloitte & Touche LLP, National Life Sciences Sector Leader.
For more information about the BioExec Institute, please visit, www.executive.berkeley.edu/programs/bioexec-institute, or contact Chelsea Hewitt, (415) 405-6385, or Chelsea@prescienceintl.com. A video overview of the program may be found here, http://www.youtube.com/watch?v=USLMifimz0s
About the UC Berkeley Center for Executive Education
Drawing from the vast resources of the Haas School of Business and the exciting business environment of the Silicon Valley and San Francisco Bay Areas, the Center for Executive Education brings together professionals of diverse background, perspectives, and experiences in the pursuit of professional and organizational success. CEE's mission is to develop, innovate and sustain programs designed to help professionals develop the skills, knowledge, and mindset to embrace change and to use it as a catalyst to success. For more information, please visit http://executive.berkeley.edu/
About Deloitte Health Sciences Practice
The mission of Deloitte's Health Sciences practice is to work with our clients -- health plans, health care providers and life sciences companies -- to help shape the new health economy and the roles they play within it. Working together, we can help our clients bring discoveries to life and improve the quality of care while creating and sustaining long-term, bottom-line success. Drawing on more than 70 years of proven Health Sciences experience with the innovation, knowledge and commitment of more than 2,700 professionals focused on the industry, we provide a complete range of audit, tax, consulting, and financial advisory services across all sectors of the industry. We offer comprehensive, customized solutions that can help our clients maximize opportunities and tackle their most pressing and complex challenges. For more information, please visit our web site at www.deloitte.com/us/lifesciences or, send an email to Keith Donnermeyer at firstname.lastname@example.org.
About Prescience International
Prescience International, operators of the San Jose BioCenter, is a firm dedicated to accelerating the commercialization and global adoption of science and technology. With industry expertise in the future of technology markets, Prescience International creates and manages centers of excellence in the form of research parks, innovation centers, research foundations, research institutes and emerging companies. The Prescience team brings a combination of business and lab experience to translate science and technology into economic wealth and social impact. Prescience's projects have won international acclaim and the companies within these projects have demonstrated that their development times and costs are cut by at least 50%. For more information, visit www.prescienceintl.com